Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
  • Overview
  • Insights
  • Recognition

About Jenny

Jenny Shmuel, Ph.D., represents clients on a range of intellectual property matters, with an emphasis on medical device and pharmaceutical technologies. She has extensive experience in pre-suit diligence, case management, expert and fact discovery, and brief writing, and has examined and cross-examined witnesses at trial.

Over the last several years, Dr. Shmuel has helped successfully defend Gilead’s HCV franchise and secured a significant damages award for a medical device manufacturer. Dr. Shmuel has represented pharmaceutical clients in competitor litigation, Hatch-Waxman litigation, and biosimilar litigation. Since joining the firm, Dr. Shmuel has worked to build Fish’s biologics/biosimilar practice. She is a frequent contributor to Fish’s Litigation Blog and regularly presents seminars and webinars on hot topics in biosimilar litigation.

Dr. Shmuel earned her Ph.D. in materials science and engineering from MIT in 2009. Her doctoral work focused on biological applications for polymer thin films.

Publications

Dr. Shmuel is a contributing author to Fish’s IP Law Essentials.

Speaking Engagements

  • Up and Coming Lawyer,” Massachusetts Lawyers Weekly (2022)
  • Named one of the “Women Worth Watching in STEM” by Profiles in Diversity Journal (2020)
Focus Areas
Education

J.D. cum laude , Harvard Law School (2012)


Ph.D., Materials Science & Engineering, Massachusetts Institute of Technology (2009)


B.S., Materials Science & Engineering, Massachusetts Institute of Technology (2004)

Admissions
  • Connecticut 2012
  • Massachusetts 2012
  • U.S. District Court for the District of Massachusetts
Memberships & Affiliations

​Women's Bar Association of Massachusetts​
Editorial Board, Biosimilar Development

What's trending with Jenny

Filter by
News
January 20, 2022
Jenny Shmuel Named “Up and Coming Lawyer” by Massachusetts Lawyers Weekly
Press Release
Recognition
News
Blog
January 11, 2022
Biosimilars 2021 Year in Review
Authors: Kayleigh E. McGlynn, Philip K. Chen, Casey M. Kraning, Jenny Shmuel, Ph.D.
Event
January 11th, 2022 | 1:30 pm EST
Webinar | Biosimilars 2021 Year in Review
Webinar
News
March 8, 2021
Fish Attorneys Author Biosimilar Development Article, "Regulatory And Legislative Actions Set The Tone For Biosimilars In 2021"
Articles
News
Blog
February 4, 2021
Biosimilars 2020 Year in Review
Authors: Kayleigh E. McGlynn, Philip K. Chen, Jenny Shmuel, Ph.D.
Event
January 28th, 2021 | 1:30 pm EST
Webinar | Biosimilars - 2020 Year in Review
Webinar
News
September 1, 2020
Fish Attorneys Author Biosimilar Development Article, "An Update On 2020 U.S. Biosimilars Regulation & Litigation"
Articles
News
Blog
August 12, 2020
How Biosimilars Are Approved and Litigated: Patent Dance Timeline
Authors: Kayleigh E. McGlynn, Cheryl Wang, Nicole Williams, Jenny Shmuel, Ph.D.
IP Law Essentials
News
August 10, 2020
Four Fish & Richardson Principals Named 2020 “Women Worth Watching in STEM” by Profiles in Diversity Journal
Press Release
Recognition
News
Blog
July 31, 2020
Introduction to Patent Term Extensions (PTE)
Authors: Tina Murphy, CIPP/US, CIPP/E, Jenny Shmuel, Ph.D., Terry G. Mahn
Blogs
IP Law Essentials
Event
July 23rd, 2020 | 1:30 pm EDT
Webinar | Biosimilars: A 2020 Mid-Year Review
Webinar
Blog
June 4, 2020
Introduction to Biologics and Biosimilars
Authors: Kayleigh E. McGlynn, Cheryl Wang, Jenny Shmuel, Ph.D.
Blogs
IP Law Essentials
load more topics
TOP